Non-Invasive Prenatal Testing Market Challenge: Reliability of test results, especially in obese women

Growth in the Non-Invasive Prenatal Testing (NIPT) industry is guided by the high probability of chromosomal anomalies with elevated maternal age, increased demand for non-invasive procedures over invasive approaches, enhanced NIPT reimbursement scenario and increased understanding of NIPT

The NGS technology, along with DNA research, has paved the way for the identification of chromosomal aberrations with growing efficiency and lowering expense. The high-risk testing industry is crowded, and continued rivalry is likely to result in substantial declines in the retail sales price of such tests. The prevalence of such studies can be improved with reduced costs in the market for reproductive genetics. The creation of new technology for NIPT is gradually increasing due to the rising awareness of the advantages of non-invasive methods.

The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.

Read more@


key findings from the report


Based on the method, ultrasound detection generated a revenue of USD 0.86 billion in 2019 and believed to rise with a CAGR of 14.0% in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.


The hospital segment expected to grow with a CAGR of 14.1% in the forecasted period due to the growing introduction of non-invasive prenatal testing coupled with rapid technological developments and groundbreaking acceptance strategies.


The trisomy application is the major contributor to the Non-Invasive Prenatal Testing Market. The trisomy application of the North America region is the major shareholder of the market and held around 45.1% of the market in the year 2019, owing to the high incidence of genetic disorders correlated with trisomy’s, such as Patau syndrome, Down syndrome, and Edward syndrome.


North America dominated the market for Non-Invasive Prenatal Testing in 2019 due to the availability of technologically advanced healthcare research system, the region's production of WGS. The North America region held approximately 48.8% of the market, followed by Europe, which contains around 25.4% market in the year 2019.


Key participants include Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others.


Request For Free Sample@


Method Outlook (Revenue, USD Billion; 2017-2027)

Ultrasound Detection

Biochemical Screening Tests

Cell-free DNA in Maternal Plasma Tests



End-Use Outlook (Revenue, USD Billion; 2017-2027)

Diagnostic Laboratories


Research Centers



Application Outlook (Revenue, USD Billion; 2017-2027)


Microdeletion Syndrome



Regional Outlook (Revenue, USD Billion; 2017-2027)

North America


Asia Pacific

Latin America



Table of Content


Chapter 1. Methodology Sources


    1.1. Prenatal Testing Market Definition

    1.2. Prenatal Testing Market Research Scope

    1.3. Prenatal Testing Market Methodology

    1.4. Prenatal Testing Market Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

   1.5. Prenatal Testing Market Estimation Technique


Chapter 2. Executive Summary


    2.1. Summary Snapshot, 2019-2027


Chapter 3. Key Insights


Chapter 4. Prenatal Testing Market Segmentation Impact Analysis




Find similar reports by Emergen Research

Smart Irrigation Controllers Market  By Type (Weather-based controllers and soil-based controllers), By End Users (Agriculture Industry and Non-Agriculture Industry), and Forecasts to 2027

Medical Devices Testing Services Market  By Phase (Clinical, Preclinical), By Service (Chemistry Test, Package Validation, Microbiology Sterility Testing, Biocompatibility Tests), Forecasts to 2027

Medical Supplies Market  By Type, By Application (Urology, Wound Care, Radiology, Respiratory, Infection Control, Cardiology, IVD, Other Applications), By End User (Hospitals, Clinics, Others), and By Region, Forecasts to 2027

Cloud Billing Market  By Component (Solution Services), By Billing Type, By Deployment Type (Private, Public), By Service Model (IaaS, PaaS, SaaS), By Organization Size (Large Enterprises, Small and Medium-Sized Enterprise), By Vertical, and By Region, Forecasts to 2027



About Emergen Research

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us: Eric Lee










Lee mas..